LATISSE (bimatoprost ophthalmic solution) 0.03% is the first and only FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
Unretouched clinical photos of actual LATISSE users. In the clinical trial, 78% of LATISSE users experienced 1-grade increase vs 18% for vehicle, and 33% experienced 2-grade increase vs 1% for vehicle, on the 4-point Global Eyelash Assessment (GEA) scale* at week 16. Individual results may vary.